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Abstract 1 
Berberine is a plant alkaloid with multiple pharmacological actions, including antidiarrhoeal 2 
activity and has been shown to inhibit Cl- secretion in distal colon. The aims of this study 3 
were to determine the molecular signalling mechanisms of action of berberine on Cl
-
 secretion 4 
and the ion transporter targets. Monolayers of T84 human colonic carcinoma cells grown in 5 
permeable supports were placed in Ussing chambers and short-circuit current measured in 6 
response to secretagogues and berberine. Whole-cell current recordings were performed in 7 
T84 cells using the patch-clamp technique. Berberine decreased forskolin-induced short-8 
circuit current
 
in a concentration-dependent manner
 
(IC50 80  8 M). In apically 9 
permeabilized monolayers and whole-cell current recordings, berberine inhibited a cAMP-10 
dependent and chromanol 293B-sensitive basolateral membrane K
+
 current by 88%, 11 
suggesting inhibition of KCNQ1 K
+
 channels. Berberine did not affect either apical Cl
-
 12 
conductance or basolateral Na
+
-K
+
-ATPase activity. Berberine stimulated p38 MAPK, PKC 13 
and PKA, but had no effect on p42/p44 MAPK and PKC. However, berberine pre-treatment 14 
prevented stimulation of p42/p44 MAPK by epidermal growth factor. The inhibitory effect of 15 
berberine on Cl
-
 secretion was partially blocked by HBDDE (65 %), an inhibitor of PKC 16 
and to a smaller extent by inhibition of p38 MAPK with SB202190 (15 %). Berberine 17 
treatment induced an increase in association between PKC and PKA with KCNQ1 and 18 
produced phosphorylation of the channel. We conclude that berberine exerts its inhibitory 19 
effect on colonic
 
Cl
-
 secretion through inhibition of basolateral KCNQ1 channels responsible 20 
for K
+
 recycling via a PKC-dependent pathway. 21 
 22 
Introduction 23 
 24 
Berberine is a benzodioxoquinolone plant alkaloid isolated from several species of Berberis 25 
and Coptis. In Chinese and Hindu medicine, berberine has been used to treat gastroenteritis, 26 
abdominal pain and diarrhoea for over two millennia. Various pharmacological actions have 27 
been described for berberine, including antimicrobial (Iwasa et al., 1998), anti-inflammatory 28 
(Ivanovska and Philipov, 1996) and cardiovascular effects (Lau et al., 2001). In several small-29 
scale clinical trials, berberine has proven effective in the treatment of secretory diarrhoea 30 
(Rabbani et al., 1987; Tang and Eisenbrand, 1992). Although its therapeutic benefit has been 31 
attributed in part to its antimicrobial and antimotility properties (Yamamoto et al., 1993), 32 
berberine has been shown to prevent epithelial electrolyte secretion in vitro in rabbit and rat 33 
intestine (Guandalini et al., 1987; Taylor and Baird, 1995).  34 
Diarrheal diseases continue to be a major cause of morbidity and mortality in children 35 
and elderly people throughout the world. Oral rehydration therapy remains the mainstay of 36 
treatment for diarrhoea (Taylor and Greenough, 1989). However, in recent years significant 37 
effort has been made in the search for antisecretory drugs that will directly inhibit secretory 38 
processes within the enterocytes (Farthing, 2006; Ma et al., 2002).  39 
Activated Cl
-
 secretion from the intestinal crypt is thought to play a major role in 40 
secretory diarrhoea of several aetiologies (Field, 2003). The generation of the electrochemical 41 
driving force required for Cl
-
 secretion by crypt epithelial cells depends on their ability to 42 
accumulate intracellular Cl
-
 ions to concentrations greater than their electrochemical 43 
equilibrium (Kunzelmann and Mall, 2002; Barrett and Keely, 2000). Cl
-
 enters the cell across 44 
the basolateral membrane through the activity of Na
+
-K
+
-2Cl
-
 cotransporters.  The 45 
cotransporter is, in turn, driven by a strong inwardly directed electrochemical Na
+
 gradient 46 
established by the basolaterally located Na
+
-K
+
-ATPase. In order to maintain the membrane 47 
potential at rest and during Cl
-
 secretion, both Na
+
 and K
+
 must be recycled out of the cell 48 
through the basolateral membrane. The Na
+
-K
+
-ATPase serves to recycle Na
+
, while 49 
 3 
basolateral potassium channels recycle K
+
 (Schultheiss and Diener, 1998). The basolateral K
+
 50 
conductance in intestinal epithelial cells is formed by at least two different types of K
+
 51 
channels, one activated by Ca
2+
-mobilizing secretagogues and the other by cAMP-dependent 52 
agonists (Heitzmann and Warth 2008). Electrophysiological studies have revealed the latter to 53 
be KCNQ1, a low conductance (1-3 pS) basolateral K
+
 channel, which is activated during 54 
cAMP-stimulated Cl
-
 secretion and inhibited by chromanol 293B and HMR-1556 (Schroeder 55 
et al., 2000; Robbins 2001). As in all secretory epithelia, the channels and transporters of the 56 
crypt epithelial cell must operate in concert to achieve vectorial ion transport. Therefore, 57 
blockade of specific basolateral K
+
 conductance would be expected to inhibit the Cl
-
 secretory 58 
process. 59 
The T84 cell line is a well-differentiated intestinal human carcinoma cell line proved 60 
to be a robust model for the study of molecular mechanisms of intestinal secretion in close to 61 
1,200 publications since the early 1980s. (Dharmsathaphorn et al. 1984). Previous studies 62 
using T84 cells, grown to confluence and mounted in Ussing chambers, have shown that 63 
berberine decreased Cl
-
 secretion in a dose-dependent manner (Taylor and Baird, 1995). More 64 
importantly, berberine attenuated
 
the large Cl
-
 secretory current produced by agents that 65 
increase intracellular
 
cAMP. However, the specific transport pathways responsible
 
for the 66 
inhibitory effect of berberine on Cl
-
 secretion have not been identified. Herein we report on a 67 
series of
 
experiments designed to clarify which epithelial transport processes
 
are affected by 68 
berberine. Using the short circuit current technique, we studied the ability of berberine to 69 
inhibit Cl
-
 secretion induced by cAMP in T84 cells. Using the pore-forming
 
antibiotics 70 
nystatin and amphotericin B to permeabilize the basolateral
 
and apical membranes 71 
respectively, we were able to isolate membrane currents
 
and assess the effects of berberine on 72 
1) the apical membrane Cl
-
 conductance, 2) the basolateral membrane Na
+
-K
+
-ATPase 73 
activity, and 3) the basolateral membrane K
+
 conductance. Also, we explored the signalling 74 
involved in the antisecretory action of berberine in particular the role of protein kinases such 75 
as PKC, PKA, mitogen-activated protein kinase (MAPK) and membrane targets such as ion 76 
channels and transporters. Our results indicate that berberine inhibits Cl
-
 secretion by 77 
decreasing the basolateral membrane K
+ 
conductance and therefore K
+
 recycling necessary for 78 
the generation of the favourable electrochemical gradient required for Cl
-
 secretion. 79 
 80 
Materials and methods 81 
 82 
 Cell Culture  83 
T84 cells (American Type Culture Collection, Manassas, VA) were cultured in a 1:1 mixture 84 
of DMEM and Ham's
 
F-12 supplemented with 10% foetal bovine serum, 1% non-essential 85 
amino acids, 50 Uml-1 penicillin, 0.05 mgml-1 streptomycin and grown onto Costar Snapwell 86 
culture inserts (Corning, Dublin Ireland) with an area of 1 cm
2
 for short circuit current 87 
measurements or onto 24 mm Costar Transwell filters (0.4 m pore) for protein assays. 88 
Experiments were conducted on confluent monolayers 8-12 days
 
after culture onto the 89 
permeable supports. 90 
 91 
Transepithelial transport studies 92 
T84 cells were grown onto Snapwell inserts and mounted in Ussing chambers (Physiologic 93 
Instruments, San Diego, CA, USA). Transepithelial potential difference
 
was clamped to zero 94 
using an EVC-4000 voltage-clamp apparatus (World Precision Instruments, UK). The 95 
transepithelial short-circuit current (ISC) was recorded using Ag-AgCl electrodes in 3M KCl 96 
agar bridges as previously described (Condliffe et al., 2001).
 
Transepithelial resistance (Rt) 97 
was calculated by
 
measuring the ISC resulting from 5-s square voltage pulses (2
 
or 4 mV) 98 
 4 
imposed across the monolayer. All preparations were allowed to equilibrate for 30 min before 99 
the experiments were performed. Amiloride (50 M) was added at the start of the experiments 100 
to block Na
+
 absorption. All experiments were performed at 37C. The ISC was defined as 101 
positive for anion flow from the basolateral to apical chamber. 102 
Specific apical Cl
-
 channel conductance and basolateral Na
+
/K
+
 pump and K
+
 channel 103 
conductances were isolated and analyzed using a well-established technique consisting of 104 
selective membrane permeabilization using ionophores as previously described (DuVall et al., 105 
1998). To investigate the activity of apical Cl
-
 conductance in isolation, the basolateral 106 
membrane was permeabilized by addition of 200gml-1 nystatin in the presence of an apical 107 
to basolateral Cl
-
 gradient. Forskolin was then added to the apical and basolateral sides of
 
the 108 
monolayers to activate the cystic fibrosis transmembrane conductance regulator (CFTR). 109 
Under these conditions, the ISC
  
represents the Cl
-
 current (ICl) as Cl
-
 moves down its 110 
concentration gradient through the CFTR channels in the apical plasma membrane. 111 
To investigate the activity of basolateral Na
+
-K
+
-ATPase activity in isolation, the 112 
apical membrane was permeabilized by addition of 10 M amphotericin B. Na+-K+-ATPase 113 
activity was examined in monolayers bathed with medium in which
 
NaCl was replaced by N-114 
methyl-D-glutamine chloride,
 
such that the final bath Na
+
 concentration was 25 mM on both 115 
sides of the monolayers. Under short-circuit
 
conditions, the resulting current is due to the 116 
transport of Na
+
 across the basolateral membrane by the Na
+
-K
+
-ATPase (INa).  117 
To investigate the activity of the basolateral K
+
 conductance in isolation, the apical 118 
membrane was permeabilized by addition of 10 M amphotericin B in the presence of an 119 
apical to basolateral
 
K
+
 gradient. Ouabain (100 M) was added to the basolateral bath to 120 
inhibit Na
+
-K
+
-ATPase. The resulting ISC
 
is due to the movement of K
+
 through channels in 121 
the basolateral membrane (IK). The use of antibiotic-based ionophores to selectively 122 
permeabilise epithelial membranes is a well-established electrophyiological protocol since the 123 
1980s to gain an insight into ion conductive properties at the opposite unpermeabilised 124 
membrane. Antibiotic ionophores used for transport studies are permselective for ions of 125 
similar size with the exception of valinomycin for K+. The establishment of large 126 
transepithelial (transmembrane) ionic gradients for the ion under study and the use of 127 
selective channel blockers aid in extracting the conductive properties of the particular 128 
rheogenic ion transport pathway as was done in this study. 129 
 130 
Patch-clamp recordings  131 
A small aliquot of Krebs solution containing single T84 cells was transferred into a 1 ml 132 
superfusion chamber mounted on the stage of an inverted microscope (Nikon Diaphot). Patch 133 
pipettes were prepared from capillary glass (GC150 F-10, Harvard Apparatus Ltd, 134 
Edenbridge, UK) using a programmable horizontal puller (DMZ-Universal Puller, Zeitz-135 
Instruments GmbH, Munich, Germany) and had a resistance of 3-6  when filled with the 136 
pipette solution. The reference electrode was an Ag-AgCl wire in direct contact with the 137 
superfusion bath. Patch–clamp apparatus consisted of a CV-203BU headstage (Axon 138 
Instruments Inc., Union City, CA) connected to an Axopatch 200B series amplifier. 139 
Experiments were performed using the whole-cell patch-clamp configuration and recorded 140 
membrane currents were filtered at 1 kHz and digitized at 5 kHz. Membrane voltage was 141 
clamped from –100mV to +100 mV with ramps of 20 mV from an initial holding potential of 142 
-50 mV. The protocols for patch-clamp and data analysis were established using pClamp 9.2 143 
software (Axon Instruments Inc.) running on a PC, and data were stored for subsequent 144 
analysis. For patch-clamp measurements, the standard bath solution contained (in mM): NaCl 145 
140, KCl 5.4, MgCl2 1, CaCl2 1.25, Glucose 12.2, and HEPES 10, buffered at pH 7.4 with 146 
NaOH. The patch pipette solution contained (in mM): K-Gluconate 95, KCl 30, Na2HPO4 4.8, 147 
KH2PO4 1.2, EGTA 1, Ca-gluconate 0.73, MgCl2 1, Na2ATP 3, Glucose 5 (pH 7.2). Drug 148 
 5 
actions were measured only after steady-state conditions were reached. All patch-clamp 149 
experiments were performed at 37C. 150 
 151 
Immunoprecipitation and Western blotting 152 
T84 cells were serum-starved for 24 hours prior to treatment. Drugs were added to the 153 
basolateral side of the cell monolayers for the required time. After treatment cells were lysed 154 
and subjected to standard 10 % SDS-PAGE and Western blotting as previously described 155 
(Dilly et al., 2004). Immunoblots were developed using
 
specific phospho-antibodies against 156 
human PKC, PKC, p42/p44 MAPK and p38 MAPK. Immunoprecipitation assays for 157 
KCNQ1 were carried out as previously described (Dilly et al., 2004). 158 
 159 
PKA assay 160 
PKA activity was detected using the PepTagtrademak Assay for Non-Radioactive Detection 161 
of cAMP-dependent protein kinase. The kit was used according to manufacturer’s instructions 162 
using 30g of protein in each reaction http://www.promega.com/resources/protocols/technical-163 
bulletins/0/peptag-assay-for-nonradioactive-detection-of-pkc-or-campdependent-protein-kinase-164 
protocol/. T 84 cells were lysed by hypotonic shock on ice for 45 min (lysis buffer: 20 mM 165 
Tris, pH 7.4, 0.5% Nonident P-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, leupeptin 1 166 
μg/μl, 500 mM dithiothreitol, 5 mM phenylmethylsulfonyl fluoride, complete mini EDTA-167 
free protease inhibitor mixture tablets (1 tablet/7 ml of lysis buffer; Roche Applied Science) 168 
and phosphatase inhibitors. 169 
 170 
 Statistical Analysis 171 
Densitometric analysis was performed using Genetools software (Syngene, Cambridge UK). 172 
Statistical analysis of the data was obtained using paired t-test for analysis between two 173 
groups. ANOVA and Tukeys post-hoc test for multiple analyses. P-values of 0.05 and less 174 
were considered to be significant. Data are expressed as means  SEM unless specifically 175 
stated to be from a representative experiment. 176 
 177 
Materials 178 
Phospho-PKCd/θ(Ser643/676), p44/p42 MAPK, phospho-p42/p44 MAPK (Thr202/Tyr204), and 179 
phospho-p38 MAPK (Thr
180
/Tyr
182
) antibodies were from Cell Signalling Technologies 180 
(Hertfordshire, UK). PKCgralpha and PKAcI antibodies were from BD Transduction 181 
Antibodies (NJ, USA). Phospho-PKC (Ser657) antibody was from Upstate (Dublin, Ireland). 182 
KCNQ1 antibody was from Santa Cruz (CA, USA). Chromanol 293B was obtained from 183 
Tocris (Avonmouth, UK). Rottlerin, clotrimazole, SB202190 and HBDDE were purchased 184 
from Calbiochem (Nottingham, UK). (3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-(4,4,4-185 
trifluorobutoxy)chroman-4-yl]-N-methylethanesulfonamide
 
 (HMR-1556) was kindly 186 
provided by Dr. Uwe Gerlach (Aventis Pharma Deutschland,
 
Frankfurt-am-Main, Germany). 187 
All other chemicals were purchased from Sigma-Aldrich (Dublin, Ireland). All drugs were 188 
dissolved in DMSO or water as stock
 
solutions and diluted appropriately.
 
The final DMSO 189 
concentration was less than
 
0.1%. 190 
 191 
Results 192 
 193 
Berberine inhibits cAMP-stimulated Cl
-
 secretion in colonic epithelial cells 194 
Short-circuit current measurements across T84 monolayers under basal conditions revealed a 195 
small ISC reflecting a low level of Cl
-
 secretion. When the epithelium was treated with 196 
forskolin (10 M), the ISC rapidly increased from 4  2 to 48  6 Acm
-2
 and remained 197 
 6 
significantly elevated for over 30 min. Berberine when added to the basolateral solution at the 198 
peak of the forskolin
 
response decreased the ISC (control 46  5 Acm
-2
, berberine 5 ± 3 199 
Acm-2; n = 8, P < 0.01) (Figure 1A). The inhibitory effect of berberine on forskolin-induced 200 
Cl
-
 secretion was concentration-dependent between 10 and 300 M with an IC50 of 80 ± 3 M 201 
(Figure 1B). No significant effect on ISC was observed when berberine was added in the 202 
absence of forskolin, however, subsequent treatment with forskolin
 
failed to increase ISC (not 203 
shown). In approximately 75% of the experiments berberine induced a small and transient 204 
increase in ISC (Figure 1A). This response was prevented by addition of BaCl2 (2 mM) to the 205 
apical bath suggesting berberine also inhibits an apical K
+
 conductance responsible for K
+
 206 
secretion (data not shown). Berberine treatment for as long as 2 hours did not decrease the 207 
transepithelial resistance Rt compared to vehicle controls, suggesting
 
that the effects of 208 
berberine, at the concentrations used in this study,
 
were not due to cytotoxicity (Table 1). 209 
 210 
Berberine effects on apical membrane Cl
-
 conductance and basolateral Na
+
-K
+
-ATPase 211 
activity and K
+
 conductance 212 
Nystatin, added to the basolateral bathing solution of T84 monolayers increased the apical 213 
membrane Cl
- 
specific current ICl from 3 ± 1 to 14 ± 2 Acm
-2
 (n = 6), This likely reflects a 214 
constitutively active apical membrane
 
Cl
-
 conductance. Subsequent addition of forskolin (10 215 
M) further increased the ICl to 88 ± 12 Acm
-2
. Treatment of T84 cell monolayers with 216 
berberine (300
 M) on either apical or basolateral bath for 15 min had no effect on either 217 
basal or forskolin-activated apical membrane ICl (Table 2). 218 
The addition of amphotericin B to the apical bathing solution containing 25 mM Na
+
 219 
increased the basolateral membrane Na
+
  specific pump current
 
INa from 3 ± 1 to 16 ± 3 220 
Acm-2 (n = 6). Under these conditions, the amphotericin-induced INa was completely
 
221 
inhibited by 100 M ouabain. When T84 monolayers were treated with berberine (300 M) 222 
for 10 min, the amphotericin-induced
 
INa was not different from that of vehicle controls (Table 223 
2). 224 
When amphotericin B was added to the apical bath in the presence of an apical to 225 
basolateral K
+
 gradient (80:5 mM) and basolateral ouabain (100 M), the IK immediately
 
226 
began to increase and reached maximal levels within 15 min (from 5
 
± 3 to 53 ± 4 Acm-2; n 227 
= 6). In these conditions, IK was almost completely inhibited by addition of BaCl2 (2 mM), 228 
chromanol 293B (10 M) or HMR-1556 (500 nM) to the basolateral bath (Figure 2A). When 229 
monolayers were treated
 
with berberine (300 M), IK was
 
rapidly inhibited (53 ± 4 to 9 ± 2 230 
Acm-2; P < 0.01, n = 6) (Figure 2B) with half-maximal inhibition produced at a 231 
concentration of 150 M (Figure 2C).  232 
 233 
Berberine effects on whole-cell potassium currents in T84 cells 234 
Berberine produced a strong inhibitory effect on forskolin-activated basolateral 235 
membrane IK in T84 monolayers (Table 2). The effect of berberine on cAMP-stimulated 236 
whole-cell currents in T84 cells was examined (Figure 3A). Forskolin (10 M) stimulated a 237 
mean maximal increase in whole-cell current of 359 ± 71 pA (at Vp = +100mV; n = 7, P < 238 
0.001). Berberine (100 M) addition to isolated T84 cells reduced the forskolin-activated 239 
current by 68% (corresponding to a reduction of 245 ± 44 pA (at Vp = +100mV, n = 7, P < 240 
0.01). Consistent with the increase in whole-cell current, forskolin stimulated an increase in 241 
the chord conductance at +100 mV (+100) from 1.7 ± 0.3 nS to 5.2 ± 0.4 nS (P < 0.001, n = 242 
7), which was reduced to 2.8 ± 0.2 nS (P < 0.01, n = 7) following treatment with berberine. 243 
The identity of the K
+
 channels underlying the current stimulated by forskolin and 244 
inhibited by berberine was investigated using a variety of K
+
 channel blockers. Chromanol 245 
293B (10 M) completely inhibited the forskolin-stimulated current below the level of the 246 
 7 
control current measured prior to the addition of forskolin (at Vp +100mV: forskolin = 665 ± 247 
193 pA; forskolin + chromanol 293B = 86 ± 51 pA; P < 0.05, n = 3) (Fig. 3B). Superfusion 248 
with chromanol 293B also reduced the forskolin-induced chord conductance at +100 mV 249 
from 7.2 ± 1.4 nS to1.2 ± 0.5 nS (P < 0.05, n = 3). Other specific K
+
  channel inhibitors (of 250 
large and small conductance, Ca
2+
-dependent K
+
 channels) such as iberiotoxin (BK, 200 nM), 251 
apamin (SK, 500 nM) and TRAM-34 (KCNN4, 500 nM) did not affect the forskolin-induced 252 
whole cell K
+
 currents. 253 
 254 
Berberine effect on protein kinases activity in T84 cells 255 
PKC activation was assessed by probing with a specific antibody to phospho-Ser657. 256 
Berberine treatment increased PKC phosphorylation levels at 5 and 10 min with fold 257 
increases of 6.4  0.8 and 7.4  1.8 respectively (n = 3, P < 0.01) compared to vehicle 258 
controls (Figure 4A). PKCactivity was measured using an antibody specific to phospho-259 
Ser
643
. Berberine treatment had no effect on PKC phosphorylation levels (5 min 1.1  0.1; 260 
10 min 0.9  0.1; n = 3) compared to vehicle controls within the time period assayed (Figure 261 
4B). These results show that berberine selectively activates the classical PKC with no effect 262 
on the novel PKC. Berberine pre-treatment activated PKA at 10 min with a fold increase of 263 
2.2  0.1 compared to vehicle controls (n = 3, P < 0.001) (Figure 4C). Pre-treatment for 10 264 
min with 100 M HBDDE, a selective PKC inhibitor at this concentration (Kashiwada et al., 265 
1994), prevented berberine-induced PKA activation (1.0  0.1; n = 3) (Figure 4C). This result 266 
indicates that PKA is activated in response to berberine and is downstream to PKC 267 
activation. 268 
Activation of p38 MAPK was assessed by probing with a specific antibody to 269 
phospho-Thr
180
/Tyr
182
. Berberine treatment induced p38 MAPK phosphorylation at 5 min 270 
with a fold increase of 1.8  0.02 (n = 3, P < 0.05) (Figure 5A). The activity of p42/p44 271 
MAPK was measured using an antibody specific to phospho-Thr
202
/Tyr
204
. Treatment with 272 
berberine had no effect on basal p42/p44 MAPK phosphorylation levels compared to vehicle 273 
controls (0.8  0.3, P < 0.04, n = 4) within the time points assayed (Figure 5B). However, pre-274 
treatment of the cells with berberine for 5 min inhibited activation of p42/p44 MAPK by 275 
epidermal growth factor (EGF 100 ngml-1) with similar potency to that of PD98059 (20 M), 276 
a specific MEK1 inhibitor that prevent receptor mediated activation of p42/p44 MAPK, (EGF 277 
10.3  1.1; berberine + EGF 1.6  0.7; PD98059 + EGF 0.6  0.1; n = 4, P < 0.01) (Figure 278 
5B). These results confirm that berberine selectively activates the p38 MAPK isoform but 279 
does not activate p42/p44 MAPK isoforms. Moreover, berberine prevents the EGF-induced 280 
activation of p42/p44 MAPK. 281 
 282 
Berberine inhibition of  cAMP-stimulated Cl
-
 secretion is mediated by protein kinases 283 
To assess the role of berberine-induced protein kinase activation on its antisecretory effect, 284 
T84 monolayers mounted in Ussing chambers were pre-treated with specific kinase inhibitors. 285 
Treatment of T84 monolayers with the PKC  inhibitor HBDDE and the specific p38 MAPK 286 
inhibitor SB202190 (10 M) had no effect on basal or forskolin-stimulated ISC. However, 287 
HBDDE significantly reduced the inhibitory effect of berberine on ISC  by 65 ± 7 % (Figure 288 
6A). SB202190 also reduced the effect of berberine but only by 14 ± 5% (Figure 6A). Co-289 
incubation with both inhibitors inhibited the effect of berberine by 82 ± 4% suggesting 290 
parallel and synergistic signalling pathways. In contrast, inhibitors of PKC (rottlerin 10 M) 291 
and p42/p44 MAPK (PD98059 20 M) failed to prevent the antisecretory effect of berberine. 292 
Figure 6B shows percentage of inhibition of the berberine antisecretory action on forskolin-293 
stimulated ISC by several kinase inhibitor treatments. 294 
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Berberine pre-treatment increased the association of PKC with the KCNQ1 channel 295 
at 5 min with a fold increase of 2.4  0.1 (n = 3, P < 0.05) (Figure 7A). Upon activation, PKA 296 
catalytic subunits (PKAcI) dissociate from their regulatory subunits and interact with their 297 
substrates. Berberine treatment increased PKAcI association with the KCNQ1 channel with a 298 
fold increase of 2.2  0.4 (n = 3, P < 0.05) (Figure 7B). These experiments demonstrate the 299 
association of two kinases, PKC and PKAcI, with the KCNQ1 channel upon treatment with 300 
berberine. 301 
 302 
 303 
Discussion 304 
The results from this study show that the plant alkaloid berberine inhibits cAMP-dependent 305 
Cl
-
 secretion through a kinase-dependent inhibition of the KCNQ1 potassium channel located 306 
at the basolateral membrane of human colonic T84 cells. These data identify the ion channel 307 
target of berberine to produce inhibition of transepithelial Cl
-
 secretion which we described in 308 
early studies in human colonic epithelia (Taylor et al., 1999). Taken together our results are 309 
consistent with the hypothesis that blockade of Cl
-
 secretion by berberine in colonic epithelia 310 
is secondary to blockade of basolateral membrane K
+
 channels involved in cAMP-regulated 311 
Cl
-
 secretory pathways. 312 
At least two types of K
+
 channels are present in T84 cells (Kunzelmann and Mall, 313 
2002; Barrett and Keely, 2000). One channel is activated by agents that elevate cytosolic Ca
2+
 314 
and has been identified as the KCNN4 channel (Warth et al., 1999). A separate K
+
 channel 315 
channel is activated by cAMP-dependent agonists. Electrophysiological and pharmacological 316 
studies have demonstrated this K
+
 conductance to correspond to the KCNQ1 channel 317 
(Schroeder et al., 2000) and this channel has been shown to be rate-limiting for secretion in 318 
colon (Preston et al. 2010). In our study, berberine significantly reduced the basolateral 319 
membrane K
+
 conductance. This conductance was stimulated by the cAMP-dependent agonist 320 
forskolin and was sensitive to basolateral addition of  Ba
2+
, a non-specific K
+
 channel blocker, 321 
and chromanol 293B and HMR-1556, two specific KCNQ1 channel blockers, suggesting the 322 
main component of the basolateral K
+
 conductance is composed of current flow through 323 
KCNQ1 channels. Similarly, berberine inhibited a cAMP-stimulated and chromanol 293B 324 
sensitive whole-cell conductance, suggesting berberine inhibits KCNQ1 channels. Berberine 325 
had no effect on the apical Cl
-
 conductance nor did it affect the basolateral Na
+
-K
+
-ATPase 326 
pump activity determined as ouabain-sensitive basolateral membrane Na
+
 current. Therefore, 327 
this data suggests berberine exerts its antisecretory effect primarily by inhibiting KCNQ1 328 
channels, thus, decreasing K
+
 recycling at the basolateral membrane. 329 
Recent studies have examined the effects of berberine on protein kinase activity in 330 
several tissues. These reports have shown that the antihyperglycemic activity of berberine is 331 
mediated by activation of p38 MAPK and AMP-activated protein kinase (Cheng et al., 2006; 332 
Lee et al., 2006). The antiproliferative activity of berberine has been reported to be mediated 333 
by inhibition of cyclin-dependent kinases and the MAPK pathway in several tissues (Mantena 334 
et al., 2006; Liang et al 2006). In T84 cells, no effect on basal p42/44 MAPK activity was 335 
observed, however, berberine did prevent EGF-induced activation of p42/44 MAPK . Several 336 
studies have described the ability of EGF receptor-mediated signalling in regulating Cl
-
 337 
secretion though MAPK (Bertelsen et al., 2004). Therefore, it is possible that berberine may 338 
also reduce Cl
-
 secretion by interfering with the EGF signalling. Also, the inhibitory effect of 339 
berberine on EGF signalling may be relevant in the antiproliferative action of berberine. 340 
Berberine activated p38 MAPK, PKA and PKC. Activation of PKA was observed to 341 
be dependent on PKC activity, and this is the first study to demonstrate berberine-induced 342 
activation of PKA and PKC. Upon activation by berberine, both kinases were shown to 343 
transiently associate with the KCNQ1 channel even though both kinases remained activated 344 
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for a longer period. Several studies have demonstrated regulation of K
+
 channels by protein 345 
kinases. We have previously shown that estrogen causes a female-gender specific inhibition 346 
of KCNQ1 channels in rat colonic crypts, producing an anti-secretory response  which is also 347 
dependent on PKA activation and association with the KCNQ1 channel (O’Mahony et al. 348 
2009). Therefore, we investigated the role of berberine-induced kinase activity on the 349 
antisecretory effect of berberine. Using specific kinase inhibitors we demonstrated that the 350 
antisecretory effect of berberine could be halved by the PKC inhibitor HBDDE. Pre-351 
treatment with SB202190, a specific inhibitor of p38 MAPK, also significantly decreased the 352 
effect of berberine on secretion, although to a much lesser degree. In agreement with these 353 
findings, several studies have shown that the phorbol ester PMA inhibits the basolateral K
+
 354 
conductance of T84 cells and that this effect reduces transepithelial Cl
-
 secretion (Reenstra, 355 
1993; Matthews et al, 1993). The molecular mechanism by which berberine-induced 356 
activation of PKC and p38 MAPK inhibits basolateral KCNQ1 channels in T84 is an 357 
important
 
goal of future studies. One possibility to be considered is a change in the 358 
phosphorylation state of the channel
 
protein, which is an important determinant of K
+
 channel 359 
activity (Kurokawa et al., 2003; Li et al., 2004; Kathöfer et al., 2003) and which we have 360 
shown to mediate the estrogen-induced inhibition of KCNQ1 in rat colonic crypts (O’Mahony 361 
et al. 2007). 362 
The present study has shown activation of PKA by berberine. It is well documented 363 
that activation of these enzyme lead to an increase in CFTR activity in colonic crypts 364 
(Kunzelmann and Mall, 2000; Barrett and Keely, 2000; Schultheiss and Diener, 1998). 365 
However, in this study berberine did not affect the apical Cl
-
 current but had an overall 366 
inhibitory effect on Cl
-
 secretion. This paradox of activation of PKA without activation of 367 
CFTR can be explained if we consider that the cAMP-PKA pathway is tightly regulated at 368 
several levels to
 
maintain specificity in the multitude of signal inputs (Tasken and Aandahl, 369 
2004; Cooper, 2005). Ligand-induced
 
changes in cAMP concentration vary in duration, 370 
amplitude, and
 
localization into the cell, and cAMP microdomains are shaped by
 
adenylyl 371 
cyclases that form cAMP as well as phosphodiesterases
 
that degrade cAMP. Different PKA 372 
isozymes with distinct biochemical
 
properties and cell-specific expression contribute to cell 373 
and
 
organ specificity. Activated kinase anchoring proteins target
 
PKA to specific substrates 374 
and distinct subcellular compartments
 
providing spatial and temporal specificity for mediation 375 
of
 
biological effects channelled through the cAMP-PKA pathway (McConnachie et al., 2006). 376 
Therefore, the activation of PKA by berberine does not necessarily imply phosphorylation 377 
and activation of CFTR located in the apical membrane. 378 
Berberine is freely permeable across human intestinal epithelia and its absorption is 379 
significantly increased by P-glycoprotein inhibitors (Pan et al. 2002).  It is possible that 380 
berberine interacts with a known receptor to effect its anti-secretory action. Recently 381 
berberine has been shown to affect the activity of sex steroid receptors including the androgen 382 
receptor (antagonist) in prostate cancer cells (Li et al. 2011) and the pregnane X receptor 383 
(agonist) in HepG2 cells (Yu et al. 2011). Berberine has been shown to enhance the 384 
anticancer effect of estrogen receptor antagonists on human breast cancer cells (Liu et al. 385 
2009). The only known receptor-mediated inhibition of KCNQ1 channels in intestine is the 386 
estrogen receptor (O'Mahony et al. 2007).  17-B estradiol (E2) inhibits Cl
-
 secretion via PKC 387 
and PKA dependent phosphorylation of the KCNQ1:KCNE3 K
+ 
channels in colonic crypts 388 
and berberine displays a remarkably similar mechanism of anti-secretory action to E2  (both 389 
inhibit KCNQ1 channels by protein kinase phosphorylation and neither molecule inhibits 390 
CFTR). It is possible that berberine modulates estrogen receptor signaling in intestinal cells to 391 
inhibit KCNQ1 channels  similar to E2. The chemical structure of berberine is similar to the 392 
novel GPR30 receptor agonist G-1 and this orphan estrogen receptor may also be a target of 393 
 10 
berberine. A hypothetical schema of the anti-secretory action of berberine in intestinal 394 
epithelium is presented in figure 8.  395 
The ability of berberine to inhibit salt and water secretion from native intestinal tissue, 396 
as evidenced by blockade of stimulated ISC in rabbit and rat colon in vitro, raises the distinct 397 
possibility that berberine and related compounds may display utility in the clinical treatment 398 
of secretory diarrhoeas. High doses of berberine have already been administered orally to 399 
humans (Rabbani et al., 1987; Tang and Eisenbrand, 1992), and can be therapeutically safe 400 
over the long term. In support of this view, we found that berberine had no detectable effect 401 
on the transepithelial resistance of T84 monolayers over a 2-hour treatment period. Thus, 402 
berberine may inhibit basal and cAMP-induced fluid secretion from intestine without 403 
affecting the net transport and absorption of nutrient substrates or absorptive capacity. In fact, 404 
berberine has been shown to stimulate Na
+
 absorption (Tai et al., 1981). Unlike most 405 
antidiarrheals, berberine exhibits several pharmacological actions useful to the treatment of 406 
secretory diarrhoea. Firstly, it reduces the cause of infection via its antimicrobial activity. 407 
Secondly, berberine increases stool transit time through the intestine via its antimotility 408 
action. Finally, as shown here, berberine decreases basolateral membrane K
+
 recycling, thus 409 
reducing the electrical driving force for whole secretory process in the enterocytes.   410 
Other laboratories have also explored the use of K
+
 channel blockers to inhibit 411 
epithelial Cl
-
 secretion. The antifungal antibiotic, clotrimazole,
 
has been shown to prevent 412 
fluid and electrolyte secretion
 
in rabbit and mouse intestine triggered by Ca
2+
- and cAMP-413 
mediated agonists via specific inhibition of basolateral
 
K
+
 conductances (Rufo et al., 1997). 414 
Furthermore, levamisole (and other phenylimidazothiazoles)
 
inhibits Ca
2+
- and cAMP-415 
activated Cl
-
 secretion in T84 cell monolayers and isolated human distal colon,
 
apparently by 416 
blocking basolateral K
+
 channels (Mun et al., 1998). Greger and colleagues noted that a group 417 
of chromanol compounds
 
selected from agents screened for the ability to block ISC in
 
isolated 418 
rabbit colon turned out to be ineffective as Cl
-
 channel blockers, but effective as blockers of 419 
K
+
 channel activity elicited by cAMP-dependent agonists. The most
 
potent of these was 420 
chromanol 293B (Lohrmann et al., 1995), which here was shown to block KCNQ1 channels 421 
in T84 cells. Chromanol 293B has been described to block CFTR currents when expressed in 422 
Xenopus oocytes (Bachmann et al. 2001) but this has not been observed in native epithelia. In 423 
our study, the KCNQ1 inhibitors, chromanol 293B and HMR-1556 were added from the 424 
basolateral side without affecting apical Cl
-
 currents. The inhibitory effects of these molecules 425 
on transepithelial Cl
-
 secretion is indirect via block of KCNQ1 channels.  Like chromanol 426 
293B, berberine also reduced the basolateral K
+
 current activated by cAMP-dependent 427 
agonists. Our finding that berberine has
 
a marked inhibitory effect on basolateral KCNQ1 428 
channel current in T84 cells highlights this component of
 
the intestinal Cl
-
 secretory process 429 
as a target for new antidiarrhoeal
 
strategies. Identification of the mechanism of kinase 430 
regulation of basolateral K
+
 channels in colonic epithelia and
 
a better understanding of the 431 
signalling processes involved may
 
provide a basis for the development of new antisecretory 432 
drugs
 
with greater potency and
 
specificity. 433 
In summary, based on the results of our previous studies in rat colon in vitro and the 434 
present studies in T84 cells monolayers, we propose that the effect of berberine on chloride 435 
ion secretion in intestine is mediated by a protein kinase dependent reduction in basolateral 436 
KCNQ1 channel activity. 437 
 438 
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Table 1. Effect of berberine on transepithelial resistance. 
Transepithelial resistance (Rt) was calculated using Ohms law by
 
measuring the ISC resulting 
from 5 seconds square voltage pulses (2
 
or 4 mV) imposed across the monolayer. 
 
 Rt,  · cm
2
 
Time (hours) Vehicle Berberine 100 μM Berberine 300 μM 
0 1302 ± 212 1235 ± 205 1301 ± 182 
1 1287 ± 234 1198 ± 192 1246 ± 235 
2 1176 ± 187 1099 ± 210 1155 ± 211 
 
Values are mean ± SEM; n = 8 for each group. 
 
Table 2. Berberine effect on membrane conductances. 
Forskolin (10 µM) was added to stimulate CFTR and cAMP-dependent K
+
 conductance. 
Berberine (300 µM) was added to the basolateral bath. The berberine effect was measured 15 
minutes after the drug addition. 
 
Treatment ICl (µA/cm
2
) INa (µA/cm
2
) IK (µA/cm
2
) 
Basal 14 ± 2 16 ± 3 53 ± 4 
Basal + berberine 12 ± 3 13 ± 3   9 ± 2 ** 
Forskolin 88 ± 12 _ 94 ± 2 
Forskolin + berberine 84 ± 10 _ 15 ± 4 ** 
 
n = 6 for each group, **P < 0.05 
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Figure Legends 
 
Figure 1. Effect of berberine on forskolin-induced Cl
-
 secretion. (A) Representative short-
circuit current recording of the effect of berberine (300 M) on forskolin-stimulated ISC in 
T84 cell monolayers. Drugs were added at arrow and remained in the bathing solutions 
throughout the experiment (B) Concentration-response curve for the antisecretory effect of 
berberine on forskolin-stimulated ISC in T84 cell monolayers. Change in ISC measured 15 min 
post berberine application at different concentrations. Values are mean  S.E.M., n = 8 for 
each point. 
 
Figure 2. Effect of berberine on basolateral K
+
 current (IK) across apically permeabilized T84 
cell monolayers. (A) Effect of KCNQ1 channel inhibitors on IK in T84 cell monolayers. 
Amphotericin B (10 M) was added to apical bath after ouabain (100 M) was added to 
basolateral bath. BaCl2 (2 mM), chromanol 293B (10 M) or HMR-1556 (500 nM) were 
added to the basolateral bath. Values were measured at the point of maximal inhibition of IK 
by each inhibitor. (B) Short-circuit currents recording of the effect of berberine (300 M, 
filled circles) on IK across T84 cells monolayers compared to a vehicle control (DMSO 
0.05%, open circles). Drugs were added at arrow and remained in the bathing solutions 
throughout the experiment.  Values are means ± S.E.M., **P < 0.01 compared to controls, n = 
6 for each group.  (C) The concentration dependence of the inhibitory effect of berberine on 
basolateral membrane K
+
 current showed a half-maximal inhibition at 150 M 
 
Figure 3. (A) Current/voltage relationships illustrating the effect of berberine (100 M) on 
the increase in whole-cell current stimulated by forskolin (10 M) in T84 cells. Traces are 
control (o), forskolin (■), and forskolin + berberine (▲). Data are mean ± SEM (*P < 0.01 
between the forskolin-stimulated current and berberine, n = 7). (B) Current/voltage 
relationships illustrating the effect of chromanol 293B (10 M) on the increase in whole-cell 
current stimulated by forskolin (10 M) in T84 cells. Traces are control (o), forskolin (■), and 
forskolin + chromanol 293B (▲). Data are mean ± S.E.M. (*P < 0.01 between the forskolin-
stimulated current and chromanol 293B, n = 3). 
 
Figure 4. Berberine effect on PKC isoforms and PKA activity in T84 cells. (A) 
Representative blot of PKC phosphorylation levels at Ser657 in cellular extracts from T84 
cells after berberine treatment (300 grmuM) for 5 and 10 min compared to vehicle controls. 
(B) Representative blot of PKC phosphorylation levels at Ser643 in cellular extracts from 
T84 after berberine treatment (300 grmuM) cells for 5 and 10 min compared to vehicle 
controls. grbeta-Actin was used as an internal control for protein loading. The graphs 
represent densitometric analysis of PKC blots or PKA activity assays. Values are given as 
fold changes in PKC phosphorylation (activation) or PKA activity respect to an untreated 
control. Values are displayed as mean  S.E.M. (n = 3 for each group, **P < 0.01). 
 
Figure 5. Berberine effect on MAPK signalling in T84 cells. (A) Representative blot of p38 
MAPK phosphorylation levels at Thr
180
/Tyr
182
 in cellular extracts from T84 cells after 
berberine treatment (300 M) for 5 and 10 min compared to vehicle controls. (B) 
Representative blot of p42/p44 MAPK phosphorylation levels at Thr
202
/Tyr
204
 in cellular 
extracts from T84 cells after berberine treatment (300 grmuM) for 5 and 10 min compared to 
vehicle controls. T84 cells were treated with EGF (100 ngml-1) for 5 min to stimulate 
p42/p44 MAPK phosphorylation. PD98059 (20 grmuM) was added 15 min prior EGF-
treatment. -Actin was used as an internal control for protein loading. The graphs represent 
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densitometric analysis of blots. Values are given as fold changes in MAPK phosphorylation 
(activation) respect to an untreated control. Values are displayed as mean  S.E.M. (n = 3 for 
each group, *P < 0.05, ***P < 0.001). 
 
Figure 6. Role of protein kinases on the antisecretory effect of berberine. (A) Short-circuit 
current recordings in T84 cell monolayers of the effect of protein kinases inhibitors on the 
antisecretory effect of berberine (300 M). Cells were pre-incubated for 15 min with HBDDE 
100M (▲), SB202190 10M (○) or vehicle DMSO 0.05% (●). (B) Mean  SEM (n = 6) 
change in total ISC caused by preincubation with several kinase inhibitors on the antisecretory 
effect of berberine on forskolin-stimulated ISC.  Values are mean  S.E.M., n = 6, *P < 0.05, 
**P < 0.01 compared to controls. 
 
Figure 7. Berberine effect on protein kinase association with KCNQ1 channel. (A) 
Representative blot of PKCassociation with the KCNQ1 channel in response to berberine 
(300 grmuM) in T84 cells. (B). Representative blot of PKACI association with the KCNQ1 
ion channel in response to berberine (300 grmuM) in T84 cells. Total KCNQ1 pools were 
immunoprecipitated from total cellular lysates using an antibody specific to KCNQ1. 
Associated PKC and PKAcI were quantified by Western blot analysis. The graphs represent 
densitometric analysis at specific time points of berberine treatment compared to vehicle 
controls. Values are given as fold changes in kinase association with KCNQ1 respect to an 
untreated control. Values are displayed as mean  S.E.M. (n = 3 for each group, *P < 0.05, 
***P < 0.001). 
 
Figure 8. Hypothetical schema of the anti-secretory action of berberine in intestinal 
epithelium. Berberine activates p38 MAPK, PKC and PKA to phosphorylate the 
KCNQ1:KCNE3 K
+
 channel causing the channel to become inactive either through closure or 
removal from the plasmamembrane. Inhibition of basolateral K
+
  channel reduces the 
electrical driving force for Cl
-
 exit across the apical membrane through CFTR and Calcium-
activated Cl
-
 channels. The receptor transducing the response to berberine may be the 
estrogen receptor or GPR30/GPCR as previously described for similar anti-secretory and 
rapid protein kinase responses to estrogen in the intestine. 
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